Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
AUTOR(ES)
Piccolomini, R
RESUMO
We examined 741 urinary tract isolates of the Morganella-Proteus-Providencia group, including the recently defined species Proteus penneri, for susceptibilities to aminoglycosides, semisynthetic penicillins, and cephalosporins. The data emphasize the importance of identification to the species level on the basis of marked species differences in patterns of susceptibility.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175007Documentos Relacionados
- Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces.
- Comparative activities of cefotiam and cefazolin against urinary tract infections with Proteus mirabilis in mice.
- Activities of oral antibiotics on Providencia strains isolated from institutionalized elderly patients with urinary tract infections.
- Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection.
- Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.
